Medicine, Health Care and Philosophy

, Volume 17, Issue 4, pp 579–597

Gut Health in the era of the Human Gut Microbiota: from metaphor to biovalue

  • Vincent Baty
  • Bruno Mougin
  • Catherine Dekeuwer
  • Gérard Carret
Scientific Contribution

Abstract

The human intestinal ecosystem, previously called the gut microflora is now known as the Human Gut Microbiota (HGM). Microbiome research has emphasized the potential role of this ecosystem in human homeostasis, offering unexpected opportunities in therapeutics, far beyond digestive diseases. It has also highlighted ethical, social and commercial concerns related to the gut microbiota. As diet factors are accepted to be the major regulator of the gut microbiota, the modulation of its composition, either by antibiotics or by food intake, should be regarded as a fascinating tool for improving the human health. Scientists, the food industry, consumers and policymakers alike are involved in this new field of nutrition. Defining how knowledge about the HGM is being translated into public perception has never been addressed before. This raises the question of metaphors associated with the HGM, and how they could be used to improve public understanding, and to influence individual decision-making on healthcare policy. This article suggests that a meeting of stakeholders from the social sciences, basic research and the food industry, taking an epistemological approach to the HGM, is needed to foster close, innovative partnerships that will help shape public perception and enable novel behavioural interventions that would benefit public health.

Keywords

Human Gut Microbiota Metaphors Biovalue Gut Health Nutrition Antibiotics Bacterial resistance 

References

  1. Asch, D.A., and K.G. Volpp. 2012. What business are we in? The emergence of health as the business of health care. New England Journal of Medicine 367: 888–889.CrossRefGoogle Scholar
  2. Atun, R., F.M. Knaul, Y. Akachi, and J. Frenk. 2012. Innovative financing for health: What is truly innovative ? Lancet 380: 2044–2049.CrossRefGoogle Scholar
  3. Bachelard, G. 2004. La poétique de l’espace, 215. Paris: Quadrige/PUF.Google Scholar
  4. Bachelard, G. 1967. La formation de l’esprit scientifique. Contribution à une psychanalyse de la connaissance objective. Paris: Librairie philosophique J. VRIN, 5e édition. Collection : Bibliothèque des textes philosophiques, 257 p.Google Scholar
  5. Baker, S.R., and L. Partyka. 2012. Relative importance of metaphor in radiology versus other medical specialties. Radiographics 32: 235–240.CrossRefGoogle Scholar
  6. Bapteste, E., and J. Dupré. 2013. Towards a processual microbial ontology. Biology and Philosophy 28: 379–404.CrossRefGoogle Scholar
  7. Baranyi, A., T. Krauseneck, and H.-B. Rothenhäusler. 2013. Overall mental distress and health-related quality of life after solid-organ transplantation: Results from a retrospective follow-up study. Health and Quality of Life Outcomes 11: 15. doi:10.1186/1477-7525-11-15.CrossRefGoogle Scholar
  8. Becker, A.E., and A. Kleinman. 2013. Mental health and the global agenda. New England Journal of Medicine 369: 66–73.CrossRefGoogle Scholar
  9. Bischoff, S.C. 2011. Gut health: A new objective in medicine? BMC Medicine 9: 24. doi:10.1186/1741-7015-9-24.CrossRefGoogle Scholar
  10. Blaser, M. 2011. Stop the killing of the beneficial bacteria. Science 476: 393–394.Google Scholar
  11. Blue, G. 2010. Food, publics, science. Public Understanding of Science 19: 147–154.CrossRefGoogle Scholar
  12. Brandt, L.J. 2013. American journal of gastroenterology lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. American Journal of Gastroenterology 108: 177–185.CrossRefGoogle Scholar
  13. Brinich, M.A., M.B. Mercer, and R.R. Sharp. 2013. An analysis of online messages about probiotics. BMC Gastroenterology 13: 5. doi:10.1186/1471-230X-13-5.CrossRefGoogle Scholar
  14. Casazza, K., K.R. Fontaine, A. Astrup, et al. 2013. Myths, presumptions, and facts about obesity. New England Journal of Medicine 368: 446–454.CrossRefGoogle Scholar
  15. Claesson, M.J., I.B. Jefferty, S. Conde, et al. 2012. Gut microbiota composition correlates with diet and health in the elderly. Nature 488: 178–184.CrossRefGoogle Scholar
  16. Clayton, E.W. 2003. Ethical, legal, and social implications of genomic medicine. New England Journal of Medicine 349: 562–569.CrossRefGoogle Scholar
  17. Cummings, J.H., J.M. Antoine, F. Azpiroz, et al. 2004. PASSCLAIM: Gut Health and immunity. European Journal of Nutrition 43(Suppl 2): II118–II173.Google Scholar
  18. Dagognet, F., F. Guery, and O. Marcel. 1989. “Mort et résurrection du paysage ?”, in Mort du paysage ?. Champ vallon: Philosophie et esthétique du paysage. 240 p.Google Scholar
  19. Dinan, T.G., Stanton, C., and J.F. Cryan. 2013. Psychobiotics: A novel class of psychotropic. Biological Psychiatry. doi: 10.1016/j.biopsych.2013.05.001.
  20. Eden, S. 2011. Food labels as boundary objects: How consumers make sense of organic and functional foods. Public Understanding of Science 20: 179–194.CrossRefGoogle Scholar
  21. El-Matary, W., R. Simpson, and N. Rickett-Burns. 2012. Fecal microbiota transplantation: Are we opening a can of worms? Gastroenterology 143: e19. doi:10.1053/j.gastro.2012.04.055.CrossRefGoogle Scholar
  22. Ezzati, M., and E. Riboli. 2013. Behavioral and dietary risk factors for noncommunicable diseases. New England Journal of Medicine 369: 954–964.CrossRefGoogle Scholar
  23. Fineberg, H.V., and D.J. Hunter. 2013. A global view of health: An unfolding series. New England Journal of Medicine 368: 78–79.CrossRefGoogle Scholar
  24. Finegold, S.M., D. Molitoris, Y. Song, et al. 2002. Gastrointestinal microflora studies in late-onset autism. Clinical Infectious Diseases 35(Suppl 1): S6–S16.CrossRefGoogle Scholar
  25. Flegal, K.M., B.K. Kit, H. Orpana, and B.I. Graubard. 2013. Association of all-cause mortality with overweight and obesity using standard body mass index categories: A systematic review and meta-analysis. Journal of the American Medical Association 309: 71–82.CrossRefGoogle Scholar
  26. Foster, J.A., and K.A. McVey Neufeld. 2013. Gut-brain axis: How the microbiome influence anxiety and depression. Trends in Neuroscience. doi:10.1016/j.tins.2013.01.005.
  27. Fox Keller, E. 1995. Refiguring life: Metaphors of twentieth-century biology. Columbia University Press, 134 p.Google Scholar
  28. Garraud, O., and J–.J. Lefrère. 2013. Are there still myths in –or associated with- transfusion ? Blood Transfusion 11: 148–150.Google Scholar
  29. Goffette, J., and J. Simon. 2012. “The internal environment: Claude Bernard’s concept and its representation in Fantastic Voyage (R. Fleisher)”, pp. 187–205, In: Landers Matthew Munoz Brian (ed.): Anatomy and the organization of knowledge, 1500–1850, London, Pickering Chatto.Google Scholar
  30. Gordon, J.I., Dewey, K., Mills, D.A., and R.M. Medzhitov. 2013. The human gut microbiota and undernutrition. Science Translational Medicine 4:137ps12. doi: 10.1126/scitranslmed.3004347.
  31. Grad, F.P. 2002. The preamble of the Constitution of the World Health Organization. Bulletin of the World Health Organization 80: 981–984.Google Scholar
  32. Greenhalgh, T., and S. Wieringa. 2011. Is it time to drop the “knowledge translation” metaphor ? A critical literature review. Journal of the Royal Society of Medicine 104: 501–509.CrossRefGoogle Scholar
  33. Hansson, M.G. 2009. Ethics and biobanks. British Journal of Cancer 100: 8–12.CrossRefGoogle Scholar
  34. Hawkes, C., and K. Buse. 2011. Public health sector and food industry interaction: It’s time to clarify the term “partnership” and be honest about underlying interests. European Journal of Public Health 21: 400–403.CrossRefGoogle Scholar
  35. Hawkins, A.K., and K.C. O’Doherty. 2011. “Who owns your poop ?”: Insights regarding the intersection of human microbiome research and the ELSI aspects of biobanking and related studies. BMC Medical Genomics 4: 72. doi:10.1186/1755-8794-4-72.CrossRefGoogle Scholar
  36. Hoffmann, C., Risti, R., Heschi, L., Stelzer, D., and M. Maier. 2013. Antibiotics and their effects: What do patients know and what is their source of information? The European Journal of Public Aug 19.Google Scholar
  37. Hudson, K.L. 2011. Genomics, health care, and society. New England Journal of Medicine 365: 1033–1041.CrossRefGoogle Scholar
  38. Hunter, D.J., and S. Reddy. 2013. Noncommunicable diseases. New England Journal of Medicine 369: 1336–1343.CrossRefGoogle Scholar
  39. Jacka, F.N., A. Mykletun, and M. Berk. 2012. Moving towards a population health approach to the primary prevention of common mental disorders. BMC Medicine 10: 149. doi:10.1186/1741-7015-10-149.CrossRefGoogle Scholar
  40. Janes, C.R., K.K. Corbett, J.H. Jones, and J. Trostle. 2012. Emerging infectious diseases: The role of social sciences. Lancet 380: 884–886.CrossRefGoogle Scholar
  41. Jones, D.S., S.H. Podolsky, and J.A. Greene. 2012. The burden of disease and the changing task of medicine. New England Journal of Medicine 366: 2333–2338.CrossRefGoogle Scholar
  42. Kahn, S.A., R. Gorawara-Bhat, and D.T. Rubin. 2012. Fecal bacteriotherapy for ulcerative colitis: Patients are ready, are we? Inflammatory Bowel Diseases 18: 676–684.CrossRefGoogle Scholar
  43. Kau, A.L., P.P. Ahern, N.W. Griffin, A.L. Goodman, and J.L. Gordon. 2012. Human nutrition, the gut microbiome, and immune system: Envisioning the future. Nature 474: 327–336.CrossRefGoogle Scholar
  44. Kelly, C.P. 2013. Fecal microbiota transplantation – An old therapy comes of age. New England Journal of Medicine 368: 474–475.CrossRefGoogle Scholar
  45. Kent, J., A. Faulkner, I. Geesink, and D. Fitzpatrick. 2006. Culturing cells, reproducing and regulating the self. Body & Society 12: 1–23.CrossRefGoogle Scholar
  46. Klingler, C. 2009. Notre seconde réserve de gènes. La Recherche 430: 31.Google Scholar
  47. Lagier, J.C., M. Million, P. Hugon, F. Armougom, and D. Raoult. 2012. Human gut microbiota: Repertoire and variations. Frontiers in Cellular and Infection Microbiology 2: 136. doi:10.3389/fcimb.2012.00136.CrossRefGoogle Scholar
  48. Lemon, K.P., Armitage, G.C., Relman, D.A., and M.A. Fischbach. 2012. Microbiota-targeted therapies: An ecological perspective. Science Translational Medicine 4: 137vr5.Google Scholar
  49. Levy, R.L., E.A. Finch, M.D. Crowell, N.J. Talley, and R.W. Jeffery. 2007. Behavioral intervention for the treatment of obesity and effectiveness data. American Journal of Gastroenterology 102: 2314–2321.CrossRefGoogle Scholar
  50. Lewis, K.H., and M.B. Rosenthal. 2011. Individual responsibility or a policy solution – Cap and trade for the U.S. diet ? New England Journal of Medicine 365: 1561–1563.CrossRefGoogle Scholar
  51. Lizé, A., McKay, R., and Z. Lewis. 2012. Gut microbiota and kin recognition. Trends in Ecology and Evolution http://dx.doi.org/10.1016/j.tree.2012.10.013.
  52. Maurice, C.F., H.J. Haiser, and P.J. Turnbaugh. 2013. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 152: 39–50.CrossRefGoogle Scholar
  53. McDonald, D., Y. Vazquez-Baeza, W.A. Walters, J.G. Caporaso, and R. Knight. 2013. From molecules to dynamic biological communities. Biology and Philosophy 28: 241–259.CrossRefGoogle Scholar
  54. McMahon, A., P. Williams, and L.C. Tapsell. 2010. Reviewing the meaning of wellbeing and wellness and their implications for food choice. Perspectives in Public Health 130: 282–286.CrossRefGoogle Scholar
  55. Mercer, M.B., M.A. Brinich, G. Geller, et al. 2012. How patients view probiotics: Findings from a multicentre study of patients with inflammatory bowel disease and irritable bowel syndrome. Journal of Clinical Gastroenterology 46: 138–144.CrossRefGoogle Scholar
  56. Merleau-Ponty, M. 1993. Phénoménologie de la perception [1945]. Paris: Gallimard. 531 p.Google Scholar
  57. Millar, M. 2012. Constraining the use of antibiotics: Applying Scanlon’s contractualism. Journal of Medical Ethics 38: 465–469.CrossRefGoogle Scholar
  58. Mitchell, R. 2010. National biobanks: Clinical labor, risk production and the creation of biovalue. Science, Technology and Human Values 35: 330–355. doi:10.1177/0162243909340267.CrossRefGoogle Scholar
  59. Mordini, E. 2007. Technology and fear: Is wonder the key ? Trends in Biotechnology 25: 544–546.CrossRefGoogle Scholar
  60. Moschen, A.R., V. Wieser, and H. Tilg. 2012. Dietary factors: Major regulators of the gut microbiota. Gut and Liver 6: 411–416.CrossRefGoogle Scholar
  61. Mouton, L. 2010. The contribution of philosophy to immunology. Presse Médicale 39: 745–746.CrossRefGoogle Scholar
  62. Murphy, E.F., P.D. Cotter, A. Hogan, et al. 2013. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut 62: 220–226.CrossRefGoogle Scholar
  63. Nancy, J.L. 2000. Le regard du portrait. Paris: Galilée. 90 p.Google Scholar
  64. Nerlich, B., R. Dingwall, and D.D. Clarke. 2002. The book of life: How the human genome project was revealed to the public. Health: An interdisciplinary journal for the social study of health, illness and medicine 6: 445–469.Google Scholar
  65. Nerlich, B., and I. Hellsten. 2004. Genomics: Shifts in metaphorical landscape between 2000 and 2003. New Genetics and Society 23: 255–268.CrossRefGoogle Scholar
  66. Nerlich, B., and I. Hellsten. 2009. Beyond the human genome: Microbes, metaphors and what it means to be human in an interconnected post-genomic world. New Genetics and Society 28: 19–36.CrossRefGoogle Scholar
  67. Norris, V., F. Molina, and A.T. Gewirtz. 2012. Hypothesis: Bacteria control host appetites. Journal of Bacteriology 195: 411–416.CrossRefGoogle Scholar
  68. O’Malley, M.A., and J. Dupré. 2007. Size doesn’t matter: Towards a more inclusive philosophy of biology. Biology and Philosophy 22: 155–191.CrossRefGoogle Scholar
  69. O’Malley, M.A. 2013. Philosophy and the microbe: A balancing act. Biology and Philosophy 28: 153–159.CrossRefGoogle Scholar
  70. Otis, L. 2008. Going with your gut: Some thoughts on language and the body. Lancet 372: 798–799.CrossRefGoogle Scholar
  71. Pérez-Cobas, A.E., M.J. Gosalbes, A. Friedrichs, et al. 2013. Gut microbiota disturbance during antibiotic therapy: A multi-omic approach. Gut 62: 1591–1601.CrossRefGoogle Scholar
  72. Persson, I. 2013. Could it be permissible to prevent the existence of morally enhanced people? Journal of Medical Ethics 38: 692–693.CrossRefGoogle Scholar
  73. Petrof, E.O., E.C. Claud, G.B. Gloor, and E. Allen-Vercoe. 2013. Microbial ecosystems therapeutics: A new paradigm in medicine ? Beneficial Microbes 4: 53–65.CrossRefGoogle Scholar
  74. Podolsky, S.H. 2012. Metchnikoff and the microbiome. Lancet 380: 1810–1811.CrossRefGoogle Scholar
  75. Pradeu, T., and E.L. Cooper. 2012. The danger theory: 20 years later. Frontiers in Immunology 3: doi: 10.3389/fimmu.2012.00287.
  76. Robbins, A., and M. Nestle. 2012. Obesity as collateral damage: A call for papers on the obesity epidemic. Journal of Public Health Policy 32: 143–145.CrossRefGoogle Scholar
  77. Saavedra, J.M., and A.M. Dattilo. 2012. Early development of intestinal microbiota: Implications for future health. Gastroenterology Clinics of North America 41: 717–731.CrossRefGoogle Scholar
  78. Sacchini, D., G.M. Liumbruno, G. Bruno, et al. 2013. Ethical and deontological issues in transfusion medicine. Blood Transfusion 11: 14–25.Google Scholar
  79. Sanchez-Villegas, A., and M.A. Martinez-Gonzalez. 2013. Diet, a new target to prevent depression ? BMC Medicine 11: 3. doi:10.1186/1741-7015-11-3.CrossRefGoogle Scholar
  80. Selgelid, M.J. 2013. Moderate eugenics and human enhancement. Medicine Health Care and Philosophy Jun 1.Google Scholar
  81. Sgard, A. 2010. “Une éthique du paysage est-elle souhaitable ?”, VertigO: La revue électronique en sciences de l’environnement [Online], Volume 10 Numéro 1 I avril 2010. URL : http://vertigo.revues.org/9472; doi : 10.4000/vertigo.9472.
  82. Slashinski, M.J., S.A. McCurdy, L.S. Achenbaum, S.N. Whitney, and A.L. McGuire. 2012. “Snake-oil”, “quack medicine”, and “industrially cultured organisms”: Biovalue and the commercialization of human microbiome research. BMC Medical Ethics 13: 28. doi:10.1186/1472-6939-13-28.CrossRefGoogle Scholar
  83. Steinbrook, R. 2006. Imposing personal responsibility for health. New England Journal of Medicine 355: 753–756.CrossRefGoogle Scholar
  84. Stuckler, D., and M. Nestle. 2012. Big food, food systems, and Global Health. PLoS Medicine 9(6): e1001242. doi:10.1371/journal.pmed.1001242.CrossRefGoogle Scholar
  85. Suleski, J., and M. Ibaraki. 2010. Scientists are talking, but mostly to each other: A quantitative analysis of research represented in mass media. Public Understanding of Science 19: 115–125.CrossRefGoogle Scholar
  86. Svalastog, A.L. 2010. Gene myths in public perceptions. Public Understanding of Science 21: 478–494.CrossRefGoogle Scholar
  87. Tamayo, C. 2008. Clinical research on probiotics: The interface between science and regulation. Clinical Infectious Diseases 46(Suppl 2): S101–S103.CrossRefGoogle Scholar
  88. Tennison, M.N. 2012. Moral transhumanism: The next step. Journal of Medicine and Philosophy 37: 405–416.CrossRefGoogle Scholar
  89. Tosh, P.K., and L.C. McDonald. 2012. Infection control in the multidrug-resistant era: Tending the human microbiome. Clinical Infectious Diseases 54: 707–713.CrossRefGoogle Scholar
  90. Trehan, I., H.S. Goldbach, L.N. LaGrone, et al. 2013. Antibiotics as part of the management of severe acute malnutrition. New England Journal of Medicine 368: 425–435.CrossRefGoogle Scholar
  91. Tremaroli, V., and F. Bäckhed. 2012. Functional interactions between the gut microbiota and host metabolism. Nature 489: 242–249.CrossRefGoogle Scholar
  92. Triggle, D.J. 2012. Nous sommes tous des bactéries: Implications for medicine, pharmacology and public health. Biochemical Pharmacology 84: 1543–1550.CrossRefGoogle Scholar
  93. Umetsu, D.T. 2012. Early exposure to germs and the Hygiene Hypothesis. Cell Research 22: 1210–1211.CrossRefGoogle Scholar
  94. van de Weele, C. 2008. How to do with metaphor ? Introduction to the issue. Configurations 16: 1–10.CrossRefGoogle Scholar
  95. Waldby, C. 2002. Stem cells, tissue cultures and the production of biovalue. Health: An Interdisciplinary Journal for the Social Study of Health. Illness and Medicine 6: 305–323.Google Scholar
  96. Waters, A.E., T. Contente-Cuomo, J. Buchhagen, et al. 2011. Multidrug-Resistant Staphylococcus aureus in US Meat and Poultry. Clinical Infectious Diseases 52: 1227–1230.CrossRefGoogle Scholar
  97. Zarraonaindia, I., D.P. Smith, and J.A. Gilbert. 2013. Beyond the genome: Community-level analysis of the microbial world. Biology and Philosophy 28: 261–282.CrossRefGoogle Scholar
  98. Zimmer, C. 2011. Our microbiomes, ourselves. Review December: The New York times - Sunday. 3.Google Scholar
  99. Zinken, J., Hellsten, I., and B. Nerlich. 2008. Discourse metaphors. In R. Dirven, R. Franck, T. Ziemke, and J. Zlatev (Eds), Body, language, and mind. Volume 2: Social situatedness. Berlin: Mouton de Gruyter, 441 p.Google Scholar
  100. Zipursky, J.S., T.I. Sidorsky, C.A. Freedman, M.N. Sidorsky, and K.B. Kirkland. 2012. Patient attitudes towards the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clinical Infectious Diseases 55: 1652–1658.CrossRefGoogle Scholar
  101. Zwart, H. 2009. From utopia to science: Challenges of personalized genomics information for health management and health enhancement. Medicine Studies 1: 155–166.CrossRefGoogle Scholar
  102. Zwart, H. 2010. Towards an eco-centric view of human existence: Implications of genomics for the environmental zone. Genomics, Society and Policy 6: 40–55.CrossRefGoogle Scholar
  103. Zwart, H. 2012. On decoding and rewriting genomes: A psychoanalytical reading of a scientific revolution. Medicine, Health Care and Philosophy 15: 337–346.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  • Vincent Baty
    • 1
    • 2
  • Bruno Mougin
    • 3
  • Catherine Dekeuwer
    • 2
  • Gérard Carret
    • 2
    • 4
  1. 1.Service de GastroentérologieClinique MutualisteLyonFrance
  2. 2.Faculté de PhilosophieUniversité LyonLyonFrance
  3. 3.Centre Christophe MérieuxbiomérieuxGrenobleFrance
  4. 4.Laboratoire de Bactériologie, Hospices Civils de LyonCentre Hospitalier Lyon SudPierre-BéniteFrance

Personalised recommendations